Crystalline forms of a phosphoinositide 3-kinase (PI3k) inhibitor

MYPI2025003191A0Undetermined Publication Date: 2021-03-04INCYTE CORP
0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025003191
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Filing Date
2019-09-04
Publication Date
2021-03-04
Patent Text Reader

Abstract

The present invention relates to salts and crystalline forms of 2-(3-(8-Amino-6- (trifluoromethyl)imidazo[1,2-a]pyrazin-3-yl)-4-methylphenyl)-3,3,3-trifluoro-2-hydroxypropanamide, crystalline forms of 8-amino-N-(2-hydroxy-2-methylpropyl)-3-(2-methyl-5-(1,1,1-trifluoro-2- hydroxypropan-2-yl)phenyl)imidazo[1,2-a]pyrazine-6-carboxamide, and crystalline forms of 8- amino-N-(2-hydroxy-2-methylpropyl)-3-(2-(methyl-d3)-5-(1,1,1-trifluoro-2-hydroxypropan-2- yl)phenyl)imidazo[1,2-a]pyrazine-6-carboxamide, which are PI3K inhibitors useful in the treatment of cancer and other diseases. [Figure 16B]
Need to check novelty before this filing date? Find Prior Art